S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update

Summary Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal der Deutschen Dermatologischen Gesellschaft 2012-03, Vol.10 (s2), p.S1-s95
Hauptverfasser: Nast, Alexander, Boehncke, Wolf-Henning, Mrowietz, Ulrich, Ockenfels, Hans-Michael, Philipp, Sandra, Reich, Kristian, Rosenbach, Thomas, Sammain, Adel, Schlaeger, Martin, Sebastian, Michael, Sterry, Wolfram, Streit, Volker, Augustin, Matthias, Erdmann, Ricardo, Klaus, Joachim, Koza, Joachim, Muller, Siegrid, Orzechowski, Hans-Dieter, Rosumeck, Stefanie, Schmid-Ott, Gerhard, Weberschock, Tobias, Rzany, Berthold
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page s95
container_issue s2
container_start_page S1
container_title Journal der Deutschen Dermatologischen Gesellschaft
container_volume 10
creator Nast, Alexander
Boehncke, Wolf-Henning
Mrowietz, Ulrich
Ockenfels, Hans-Michael
Philipp, Sandra
Reich, Kristian
Rosenbach, Thomas
Sammain, Adel
Schlaeger, Martin
Sebastian, Michael
Sterry, Wolfram
Streit, Volker
Augustin, Matthias
Erdmann, Ricardo
Klaus, Joachim
Koza, Joachim
Muller, Siegrid
Orzechowski, Hans-Dieter
Rosumeck, Stefanie
Schmid-Ott, Gerhard
Weberschock, Tobias
Rzany, Berthold
description Summary Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence‐based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque‐type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).
doi_str_mv 10.1111/j.1610-0387.2012.07919.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_993912408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1020854198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5319-367b58c70a90fc68bc649ff499308e7d1ac74a43a4b0e6e7e07ae4d7e08f113b3</originalsourceid><addsrcrecordid>eNqNkE1P3DAQhq2qqFDav4B8gx4SxrET2wcOFR-7SCuK1KIeLSeZgJdssrUTuvx7nC7sEdWXeSU_74z0EEIZpCy-02XKCgYJcCXTDFiWgtRMp5sP5GD38XGXpd4nn0NYAmS5AvhE9rOMqwIkPyC3PzlN6Gx0Nbauw0D7jg4PSAePdlhhN9C-oevQe2eDC_RpbO-tj-HksrtvXXigT-iD67tvKb1b13bAL2SvsW3Ar6_zkNxdXf46nyeLH7Pr8--LpMo50wkvZJmrSoLV0FSFKqtC6KYRWnNQKGtmKyms4FaUgAVKBGlR1HGqhjFe8kNyvN279v2fEcNgVi5U2La2w34MJi7SLBOgInnyLskgA5ULpidUbdHK9yF4bMzau5X1zxEyk3mzNJNUMwk2k3nzz7zZxOrR65WxXGG9K76pjsDZFvjrWnz-78Xm4mI2pdhPtn0XBtzs-tY_mkJymZvfNzMjrtj85rZYmDl_AcZVnzE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020854198</pqid></control><display><type>article</type><title>S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Nast, Alexander ; Boehncke, Wolf-Henning ; Mrowietz, Ulrich ; Ockenfels, Hans-Michael ; Philipp, Sandra ; Reich, Kristian ; Rosenbach, Thomas ; Sammain, Adel ; Schlaeger, Martin ; Sebastian, Michael ; Sterry, Wolfram ; Streit, Volker ; Augustin, Matthias ; Erdmann, Ricardo ; Klaus, Joachim ; Koza, Joachim ; Muller, Siegrid ; Orzechowski, Hans-Dieter ; Rosumeck, Stefanie ; Schmid-Ott, Gerhard ; Weberschock, Tobias ; Rzany, Berthold</creator><creatorcontrib>Nast, Alexander ; Boehncke, Wolf-Henning ; Mrowietz, Ulrich ; Ockenfels, Hans-Michael ; Philipp, Sandra ; Reich, Kristian ; Rosenbach, Thomas ; Sammain, Adel ; Schlaeger, Martin ; Sebastian, Michael ; Sterry, Wolfram ; Streit, Volker ; Augustin, Matthias ; Erdmann, Ricardo ; Klaus, Joachim ; Koza, Joachim ; Muller, Siegrid ; Orzechowski, Hans-Dieter ; Rosumeck, Stefanie ; Schmid-Ott, Gerhard ; Weberschock, Tobias ; Rzany, Berthold ; Deutsche Dermatologische Gesellschaft (DDG) ; Berufsverband Deutscher Dermatologen (BVDD)</creatorcontrib><description>Summary Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence‐based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque‐type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).</description><identifier>ISSN: 1610-0379</identifier><identifier>EISSN: 1610-0387</identifier><identifier>DOI: 10.1111/j.1610-0387.2012.07919.x</identifier><identifier>PMID: 22386073</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Administration, Topical ; Adult ; Dermatologic Agents - administration &amp; dosage ; Dermatology - standards ; Humans ; Inflammatory diseases ; Practice Guidelines as Topic ; Psoriasis - diagnosis ; Psoriasis - therapy ; psoriasis vulgaris ; Quality of Health Care ; Quality of life ; Skin diseases ; Ultraviolet Therapy - standards</subject><ispartof>Journal der Deutschen Dermatologischen Gesellschaft, 2012-03, Vol.10 (s2), p.S1-s95</ispartof><rights>Psoriasis‐Leitliniengruppe der DDG • JDDG © Blackwell Verlag GmbH</rights><rights>Psoriasis-Leitliniengruppe der DDG • JDDG © Blackwell Verlag GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5319-367b58c70a90fc68bc649ff499308e7d1ac74a43a4b0e6e7e07ae4d7e08f113b3</citedby><cites>FETCH-LOGICAL-c5319-367b58c70a90fc68bc649ff499308e7d1ac74a43a4b0e6e7e07ae4d7e08f113b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1610-0387.2012.07919.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1610-0387.2012.07919.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22386073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nast, Alexander</creatorcontrib><creatorcontrib>Boehncke, Wolf-Henning</creatorcontrib><creatorcontrib>Mrowietz, Ulrich</creatorcontrib><creatorcontrib>Ockenfels, Hans-Michael</creatorcontrib><creatorcontrib>Philipp, Sandra</creatorcontrib><creatorcontrib>Reich, Kristian</creatorcontrib><creatorcontrib>Rosenbach, Thomas</creatorcontrib><creatorcontrib>Sammain, Adel</creatorcontrib><creatorcontrib>Schlaeger, Martin</creatorcontrib><creatorcontrib>Sebastian, Michael</creatorcontrib><creatorcontrib>Sterry, Wolfram</creatorcontrib><creatorcontrib>Streit, Volker</creatorcontrib><creatorcontrib>Augustin, Matthias</creatorcontrib><creatorcontrib>Erdmann, Ricardo</creatorcontrib><creatorcontrib>Klaus, Joachim</creatorcontrib><creatorcontrib>Koza, Joachim</creatorcontrib><creatorcontrib>Muller, Siegrid</creatorcontrib><creatorcontrib>Orzechowski, Hans-Dieter</creatorcontrib><creatorcontrib>Rosumeck, Stefanie</creatorcontrib><creatorcontrib>Schmid-Ott, Gerhard</creatorcontrib><creatorcontrib>Weberschock, Tobias</creatorcontrib><creatorcontrib>Rzany, Berthold</creatorcontrib><creatorcontrib>Deutsche Dermatologische Gesellschaft (DDG)</creatorcontrib><creatorcontrib>Berufsverband Deutscher Dermatologen (BVDD)</creatorcontrib><title>S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update</title><title>Journal der Deutschen Dermatologischen Gesellschaft</title><addtitle>J Dtsch Dermatol Ges</addtitle><description>Summary Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence‐based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque‐type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).</description><subject>Administration, Topical</subject><subject>Adult</subject><subject>Dermatologic Agents - administration &amp; dosage</subject><subject>Dermatology - standards</subject><subject>Humans</subject><subject>Inflammatory diseases</subject><subject>Practice Guidelines as Topic</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - therapy</subject><subject>psoriasis vulgaris</subject><subject>Quality of Health Care</subject><subject>Quality of life</subject><subject>Skin diseases</subject><subject>Ultraviolet Therapy - standards</subject><issn>1610-0379</issn><issn>1610-0387</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1P3DAQhq2qqFDav4B8gx4SxrET2wcOFR-7SCuK1KIeLSeZgJdssrUTuvx7nC7sEdWXeSU_74z0EEIZpCy-02XKCgYJcCXTDFiWgtRMp5sP5GD38XGXpd4nn0NYAmS5AvhE9rOMqwIkPyC3PzlN6Gx0Nbauw0D7jg4PSAePdlhhN9C-oevQe2eDC_RpbO-tj-HksrtvXXigT-iD67tvKb1b13bAL2SvsW3Ar6_zkNxdXf46nyeLH7Pr8--LpMo50wkvZJmrSoLV0FSFKqtC6KYRWnNQKGtmKyms4FaUgAVKBGlR1HGqhjFe8kNyvN279v2fEcNgVi5U2La2w34MJi7SLBOgInnyLskgA5ULpidUbdHK9yF4bMzau5X1zxEyk3mzNJNUMwk2k3nzz7zZxOrR65WxXGG9K76pjsDZFvjrWnz-78Xm4mI2pdhPtn0XBtzs-tY_mkJymZvfNzMjrtj85rZYmDl_AcZVnzE</recordid><startdate>201203</startdate><enddate>201203</enddate><creator>Nast, Alexander</creator><creator>Boehncke, Wolf-Henning</creator><creator>Mrowietz, Ulrich</creator><creator>Ockenfels, Hans-Michael</creator><creator>Philipp, Sandra</creator><creator>Reich, Kristian</creator><creator>Rosenbach, Thomas</creator><creator>Sammain, Adel</creator><creator>Schlaeger, Martin</creator><creator>Sebastian, Michael</creator><creator>Sterry, Wolfram</creator><creator>Streit, Volker</creator><creator>Augustin, Matthias</creator><creator>Erdmann, Ricardo</creator><creator>Klaus, Joachim</creator><creator>Koza, Joachim</creator><creator>Muller, Siegrid</creator><creator>Orzechowski, Hans-Dieter</creator><creator>Rosumeck, Stefanie</creator><creator>Schmid-Ott, Gerhard</creator><creator>Weberschock, Tobias</creator><creator>Rzany, Berthold</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201203</creationdate><title>S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update</title><author>Nast, Alexander ; Boehncke, Wolf-Henning ; Mrowietz, Ulrich ; Ockenfels, Hans-Michael ; Philipp, Sandra ; Reich, Kristian ; Rosenbach, Thomas ; Sammain, Adel ; Schlaeger, Martin ; Sebastian, Michael ; Sterry, Wolfram ; Streit, Volker ; Augustin, Matthias ; Erdmann, Ricardo ; Klaus, Joachim ; Koza, Joachim ; Muller, Siegrid ; Orzechowski, Hans-Dieter ; Rosumeck, Stefanie ; Schmid-Ott, Gerhard ; Weberschock, Tobias ; Rzany, Berthold</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5319-367b58c70a90fc68bc649ff499308e7d1ac74a43a4b0e6e7e07ae4d7e08f113b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Topical</topic><topic>Adult</topic><topic>Dermatologic Agents - administration &amp; dosage</topic><topic>Dermatology - standards</topic><topic>Humans</topic><topic>Inflammatory diseases</topic><topic>Practice Guidelines as Topic</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - therapy</topic><topic>psoriasis vulgaris</topic><topic>Quality of Health Care</topic><topic>Quality of life</topic><topic>Skin diseases</topic><topic>Ultraviolet Therapy - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nast, Alexander</creatorcontrib><creatorcontrib>Boehncke, Wolf-Henning</creatorcontrib><creatorcontrib>Mrowietz, Ulrich</creatorcontrib><creatorcontrib>Ockenfels, Hans-Michael</creatorcontrib><creatorcontrib>Philipp, Sandra</creatorcontrib><creatorcontrib>Reich, Kristian</creatorcontrib><creatorcontrib>Rosenbach, Thomas</creatorcontrib><creatorcontrib>Sammain, Adel</creatorcontrib><creatorcontrib>Schlaeger, Martin</creatorcontrib><creatorcontrib>Sebastian, Michael</creatorcontrib><creatorcontrib>Sterry, Wolfram</creatorcontrib><creatorcontrib>Streit, Volker</creatorcontrib><creatorcontrib>Augustin, Matthias</creatorcontrib><creatorcontrib>Erdmann, Ricardo</creatorcontrib><creatorcontrib>Klaus, Joachim</creatorcontrib><creatorcontrib>Koza, Joachim</creatorcontrib><creatorcontrib>Muller, Siegrid</creatorcontrib><creatorcontrib>Orzechowski, Hans-Dieter</creatorcontrib><creatorcontrib>Rosumeck, Stefanie</creatorcontrib><creatorcontrib>Schmid-Ott, Gerhard</creatorcontrib><creatorcontrib>Weberschock, Tobias</creatorcontrib><creatorcontrib>Rzany, Berthold</creatorcontrib><creatorcontrib>Deutsche Dermatologische Gesellschaft (DDG)</creatorcontrib><creatorcontrib>Berufsverband Deutscher Dermatologen (BVDD)</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal der Deutschen Dermatologischen Gesellschaft</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nast, Alexander</au><au>Boehncke, Wolf-Henning</au><au>Mrowietz, Ulrich</au><au>Ockenfels, Hans-Michael</au><au>Philipp, Sandra</au><au>Reich, Kristian</au><au>Rosenbach, Thomas</au><au>Sammain, Adel</au><au>Schlaeger, Martin</au><au>Sebastian, Michael</au><au>Sterry, Wolfram</au><au>Streit, Volker</au><au>Augustin, Matthias</au><au>Erdmann, Ricardo</au><au>Klaus, Joachim</au><au>Koza, Joachim</au><au>Muller, Siegrid</au><au>Orzechowski, Hans-Dieter</au><au>Rosumeck, Stefanie</au><au>Schmid-Ott, Gerhard</au><au>Weberschock, Tobias</au><au>Rzany, Berthold</au><aucorp>Deutsche Dermatologische Gesellschaft (DDG)</aucorp><aucorp>Berufsverband Deutscher Dermatologen (BVDD)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update</atitle><jtitle>Journal der Deutschen Dermatologischen Gesellschaft</jtitle><addtitle>J Dtsch Dermatol Ges</addtitle><date>2012-03</date><risdate>2012</risdate><volume>10</volume><issue>s2</issue><spage>S1</spage><epage>s95</epage><pages>S1-s95</pages><issn>1610-0379</issn><eissn>1610-0387</eissn><abstract>Summary Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence‐based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque‐type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22386073</pmid><doi>10.1111/j.1610-0387.2012.07919.x</doi><tpages>95</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1610-0379
ispartof Journal der Deutschen Dermatologischen Gesellschaft, 2012-03, Vol.10 (s2), p.S1-s95
issn 1610-0379
1610-0387
language eng
recordid cdi_proquest_miscellaneous_993912408
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Administration, Topical
Adult
Dermatologic Agents - administration & dosage
Dermatology - standards
Humans
Inflammatory diseases
Practice Guidelines as Topic
Psoriasis - diagnosis
Psoriasis - therapy
psoriasis vulgaris
Quality of Health Care
Quality of life
Skin diseases
Ultraviolet Therapy - standards
title S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A42%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S3%20-%20Guidelines%20on%20the%20treatment%20of%20psoriasis%20vulgaris%20(English%20version).%20Update&rft.jtitle=Journal%20der%20Deutschen%20Dermatologischen%20Gesellschaft&rft.au=Nast,%20Alexander&rft.aucorp=Deutsche%20Dermatologische%20Gesellschaft%20(DDG)&rft.date=2012-03&rft.volume=10&rft.issue=s2&rft.spage=S1&rft.epage=s95&rft.pages=S1-s95&rft.issn=1610-0379&rft.eissn=1610-0387&rft_id=info:doi/10.1111/j.1610-0387.2012.07919.x&rft_dat=%3Cproquest_cross%3E1020854198%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020854198&rft_id=info:pmid/22386073&rfr_iscdi=true